«The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans». Current Drug Metabolism3 (6): 561–97. December 2002. doi:10.2174/1389200023337054. PMID12369887.
«Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes». Chemical Reviews104 (9): 3947–80. September 2004. doi:10.1021/cr020443g. PMID15352783.
«Spin state control of the hepatic cytochrome P450 redox potential». Biochemical and Biophysical Research Communications90 (3): 925–32. October 1979. doi:10.1016/0006-291X(79)91916-8. PMID228675.
«Cytochrome p450 and chemical toxicology». Chemical Research in Toxicology21 (1): 70–83. January 2008. doi:10.1021/tx700079z. PMID18052394. (Metabolism in this context is the chemical modification or degradation of drugs.)
Zahno, A; Brecht, K; Morand, R; Maseneni, S; Török, M; Lindinger, PW; Krähenbühl, S (1 February 2011). «The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.». Biochem Pharmacol81 (3): 432–41. doi:10.1016/j.bcp.2010.11.002. PMID21070748.
«Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort». Toxicology217 (2–3): 194–205. January 2006. doi:10.1016/j.tox.2005.09.010. PMID16271822.
«An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies». Phytomedicine11 (2–3): 98–104. February 2004. doi:10.1078/0944-7113-00379. PMID15070158.
«Inhibition of human liver cytochrome P450 by star fruit juice». Journal of Pharmacy & Pharmaceutical Sciences10 (4): 496–503. 2007. doi:10.18433/j30593. PMID18261370.
«Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components». Drug Metabolism and Disposition31 (11): 1391–7. November 2003. doi:10.1124/dmd.31.11.1391. PMID14570772.
«Aflatoxin B1 in poultry: toxicology, metabolism and prevention». Research in Veterinary Science89 (3): 325–31. December 2010. doi:10.1016/j.rvsc.2010.04.011. PMID20462619.
«Metabolism of aflatoxin B1 in turkey liver microsomes: the relative roles of cytochromes P450 1A5 and 3A37». Toxicology and Applied Pharmacology254 (3): 349–54. August 2011. doi:10.1016/j.taap.2011.05.010. PMID21616088.
«Dissecting the insecticide-resistance- associated cytochrome P450 gene Cyp6g1». Pest Management Science64 (6): 639–45. June 2008. doi:10.1002/ps.1567. PMID18338338.
«The preponderance of P450s in the Mycobacterium tuberculosis genome». Trends in Microbiology14 (5): 220–8. May 2006. doi:10.1016/j.tim.2006.03.002. PMID16581251.
«Investigating conservation of the albaflavenone biosynthetic pathway and CYP170 bifunctionality in streptomycetes». The FEBS Journal279 (9): 1640–9. May 2012. doi:10.1111/j.1742-4658.2011.08447.x. PMID22151149.
«The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans». Current Drug Metabolism3 (6): 561–97. December 2002. doi:10.2174/1389200023337054. PMID12369887.
«Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes». Chemical Reviews104 (9): 3947–80. September 2004. doi:10.1021/cr020443g. PMID15352783.
«Spin state control of the hepatic cytochrome P450 redox potential». Biochemical and Biophysical Research Communications90 (3): 925–32. October 1979. doi:10.1016/0006-291X(79)91916-8. PMID228675.
«Cytochrome p450 and chemical toxicology». Chemical Research in Toxicology21 (1): 70–83. January 2008. doi:10.1021/tx700079z. PMID18052394. (Metabolism in this context is the chemical modification or degradation of drugs.)
Zahno, A; Brecht, K; Morand, R; Maseneni, S; Török, M; Lindinger, PW; Krähenbühl, S (1 February 2011). «The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells.». Biochem Pharmacol81 (3): 432–41. doi:10.1016/j.bcp.2010.11.002. PMID21070748.
«Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort». Toxicology217 (2–3): 194–205. January 2006. doi:10.1016/j.tox.2005.09.010. PMID16271822.
«An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies». Phytomedicine11 (2–3): 98–104. February 2004. doi:10.1078/0944-7113-00379. PMID15070158.
«Inhibition of human liver cytochrome P450 by star fruit juice». Journal of Pharmacy & Pharmaceutical Sciences10 (4): 496–503. 2007. doi:10.18433/j30593. PMID18261370.
«Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components». Drug Metabolism and Disposition31 (11): 1391–7. November 2003. doi:10.1124/dmd.31.11.1391. PMID14570772.
«Aflatoxin B1 in poultry: toxicology, metabolism and prevention». Research in Veterinary Science89 (3): 325–31. December 2010. doi:10.1016/j.rvsc.2010.04.011. PMID20462619.
«Metabolism of aflatoxin B1 in turkey liver microsomes: the relative roles of cytochromes P450 1A5 and 3A37». Toxicology and Applied Pharmacology254 (3): 349–54. August 2011. doi:10.1016/j.taap.2011.05.010. PMID21616088.
«Dissecting the insecticide-resistance- associated cytochrome P450 gene Cyp6g1». Pest Management Science64 (6): 639–45. June 2008. doi:10.1002/ps.1567. PMID18338338.
«The preponderance of P450s in the Mycobacterium tuberculosis genome». Trends in Microbiology14 (5): 220–8. May 2006. doi:10.1016/j.tim.2006.03.002. PMID16581251.
«Investigating conservation of the albaflavenone biosynthetic pathway and CYP170 bifunctionality in streptomycetes». The FEBS Journal279 (9): 1640–9. May 2012. doi:10.1111/j.1742-4658.2011.08447.x. PMID22151149.
«Biochemical basis for the activity and selectivity of oral antifungal drugs». British Journal of Clinical Practice. Supplement71: 41–6. September 1990. PMID2091733.